Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase 2 Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume

被引：0

作者：

Hutchings, Martin ^{[1
,2
]}

Carlo-Stella, Carmelo ^{[3
,4
]}

Morschhauser, Franck ^{[5
,6
]}

Falchi, Lorenzo ^{[7
]}

Bachy, Emmanuel ^{[8
]}

Cartron, Guillaume ^{[9
]}

Khan, Cyrus ^{[10
]}

Tani, Monica ^{[11
]}

Martinez-Lopez, Joaquin ^{[12
]}

Bartlett, Nancy L. ^{[13
]}

Salar, Antonio ^{[14
]}

Brody, Joshua ^{[15
]}

Leppa, Sirpa ^{[16
,17
]}

Baumlin, Pauline

Mulvihill, Estefania ^{[18
]}

Relf, James ^{[19
]}

Xie, Yuying ^{[20
]}

Kaufman, Derrick ^{[21
]}

Lundberg, Linda

Dickinson, Michael ^{[22
,23
]}

机构：

[1] Rigshosp, Copenhagen, Denmark

[2] Univ Copenhagen, Copenhagen, Denmark

[3] Humanitas Univ, Milan, Italy

[4] IRCCS Humanitas Res Hosp, Milan, Italy

[5] Hop Claude Huriez, Lille, France

[6] CHU Lille, Lille, France

[7] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY USA

[8] Ctr Hosp Lyon Sud, Lyon, France

[9] CHU Montpellier, Montpellier, France

[10] Allegheny Hlth Network, Pittsburgh, PA USA

[11] Osped Santa Maria Croci, Ravenna, Italy

[12] Univ Complutense Madrid, Hosp Univ 12 Octubre, Dept Hematol, Spanish Natl Canc Res Ctr CNIO, Madrid, Spain

[13] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA

[14] Hosp Mar, Dept Hematol, Barcelona, Spain

[15] Tisch Canc Inst, New York, NY USA

[16] Univ Helsinki, Helsinki, Finland

[17] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland

[18] F Hoffmann Roche Ltd, Basel, Switzerland

[19] Roche Prod Ltd, Welwyn Garden City, Herts, England

[20] Hoffmann La Roche Ltd, Mississauga, ON, Canada

[21] Genentech Inc, San Francisco, CA USA

[22] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[23] Univ Melbourne, Melbourne, Vic, Australia

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

ABCL; non-Hodgkin lymphoma; bispecific antibody therapy; aggressive lymphoma; clinical trial; phase; 2;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ABCL-340

引用

页码：S473 / S473

页数：1